Incyte (INCY) Cash from Operations (2010 - 2026)
Incyte (INCY) posted Cash from Operations of 369351000.0 for Q1 2026, down 32.02% on a QoQ basis from 543301000.0 in Q4 2025, and up 38.82% year-over-year from 266067000.0 in Q1 2025.
Incyte (INCY) Cash from Operations (2010 - 2026) Analysis & Trends
Incyte's Cash from Operations history runs 17 years deep, the most recent figure standing at 369351000.0 for Q1 2026.
- Quarterly Cash from Operations rose 38.82% year-over-year to 369351000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1516782000.0 (up 296.45% YoY) and the FY2025 annual result came in at 1413498000.0, up 321.52% from the prior year.
- Cash from Operations was 369351000.0 for Q1 2026 at Incyte, down from 543301000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 559389000.0 in Q3 2025 and bottomed at 575563000.0 in Q2 2024.
- A 5-year average of 210859647.06 and a median of 266067000.0 in 2025 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 307.2% in 2024, while the deepest fall reached 287.77% in 2024.
- Incyte's Cash from Operations stood at 283662000.0 in 2022, then plunged by 47.92% to 147729000.0 in 2023, then jumped by 158.05% to 381218000.0 in 2024, then jumped by 42.52% to 543301000.0 in 2025, then tumbled by 32.02% to 369351000.0 in 2026.
- Business Quant data shows INCY's Cash from Operations at 369351000.0 in Q1 2026, 543301000.0 in Q4 2025, and 559389000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 369.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369.35 Mn |
| Mar 31, 2026 | 369.35 Mn |
| Dec 31, 2025 | 543.30 Mn |
| Dec 31, 2025 | 543.30 Mn |
| Sep 30, 2025 | 559.39 Mn |
| Sep 30, 2025 | 559.39 Mn |
| Jun 30, 2025 | 44.74 Mn |
| Jun 30, 2025 | 44.74 Mn |
| Mar 31, 2025 | 266.07 Mn |
| Mar 31, 2025 | 266.07 Mn |
| Dec 31, 2024 | 381.22 Mn |
| Dec 31, 2024 | 381.22 Mn |
| Sep 30, 2024 | 310.87 Mn |
| Sep 30, 2024 | 310.87 Mn |
| Jun 30, 2024 | -575.56 Mn |
| Jun 30, 2024 | -575.56 Mn |
| Mar 31, 2024 | 218.81 Mn |
| Mar 31, 2024 | 218.81 Mn |
| Dec 31, 2023 | 147.73 Mn |
| Dec 31, 2023 | 147.73 Mn |